Results 161 to 170 of about 72,871 (224)

Persistent SARS-CoV-2 Infection in an Immunocompromised Host Treated Successfully With the Japanese Herbal Medicine, Mao-to: A Case Report. [PDF]

Am J Case Rep
Yamada T, Sonoda S, Otsuka M, Shirai T, Tateishi T, Furusawa H, Miyazaki Y.   +6 more
europepmc   +1 more source

Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIV. [PDF]

Antimicrob Agents Chemother
Tsirizani L, Waalewijn H, Szubert A, Mulenga V, Chabala C, Bwakura-Dangarembizi M, Chitsamatanga M, Rutebarika DA, Musiime V, Kasozi M, Lugemwa A, McIlleron HM, Burger DM, Gibb DM, Colbers A, Denti P, Wasmann RE, CHAPAS-4 trial team.   +17 more
europepmc   +1 more source

Physiologically-Based Pharmacokinetics of Ribociclib Drug-Drug Interactions and Organ Impairment Pharmacokinetics in Early Breast Cancer. [PDF]

Pharmaceuticals (Basel)
Ji Y, Huth F, Wang C, Schiller H, Combes FP, Crown J, Fasching PA, Zarate JP, Untch M.   +8 more
europepmc   +1 more source

HIV Status and COVID-19 Treatment Disparities in the US National Clinical Cohort Collaborative. [PDF]

Open Forum Infect Dis
Essam Nkodo EN, Maheria P, Hurwitz E, Anzalone AJ, Li D, Islam JY, Sun J, Varley CD, Butzin-Dozier Z, Safo SE, Kirksey K, Hassan SA, Camacho-Rivera M, Patel RC, Fadul N.   +14 more
europepmc   +1 more source

Drug-related problems and challenges encountered by pharmacists in nirmatrelvir/ritonavir counselling during the covid-19 pandemic: a multi-center study. [PDF]

Sci Rep
Balan S, Mohan K, Liang VHW, Ghazali HH, Suan CL, Chee CC, En KW, Makhdzir LF, Samsuri NS, Tamyes NMM, Lim JN, Azami NAMN, Samad S, Singh KKC, Khan NN, Chamati SH, Hassan N, Ping KH, Nordin F, Hoong LW, Bakar AAA.   +20 more
europepmc   +1 more source

Oral Lamivudine for Extended HIV Postnatal Prophylaxis. [PDF]

Paediatr Drugs
Van de Perre P, Meda N, Tassembedo S, Moles JP, Kankasa C, Mennecier A, Mwiya M, Nagot N, Tylleskär T.   +8 more
europepmc   +1 more source

Clinical characteristics of patients with chronic hepatitis c infection at initial presentation to tertiary care in an Asian middle-income country [PDF]

, 2018
Azzeri, Amirah, Dahlui, Maznah, Kamarulzaman, Adeeba, McDonald, Scott A., Mohamed, Rosmawati, Shabaruddin, Fatiha Hana, Tan, Soek-Siam   +6 more
core  

Prevalence and correlates of hyperbilirubinemia among people living with HIV (PLHIV) receiving atazanavir boosted with ritonavir (ATV/r). [PDF]

BMC Gastroenterol
Farrokhi H, Shahmohamadi E, Pashaei A, Emadi Koochak H, Nooralioghli Parikhani S, Fathi Amrollah M, Mirzapour P, Dehghan Manshadi SA, SeyedAlinaghi S, Hackett D.   +9 more
europepmc   +1 more source

Paxlovid utilization and social vulnerability: trends in Connecticut from 2022 to 2023. [PDF]

Antimicrob Steward Healthc Epidemiol
Hohenstein L, Maloney M, Banach DB.
europepmc   +1 more source

Successful Treatment of Multiple Myeloma Complicated With SARS-CoV-2 Infection: A Case Report. [PDF]

Case Rep Med
Meng Y, Duan B, Gao L, Huang W, Wan F.
europepmc   +1 more source